Trastuzumab - an overview

33-Breast metastatic trastuzumab three weekly trastuzumab In 2006, trastuzumab plus chemotherapy was approved to treat patients after their HER2-overexpressing breast tumors were surgically removed trastuzumab If you're having trastuzumab to treat primary breast cancer after surgery, it's usually given for 1 year Some people may be offered

trastuzumab The story of trastuzumab begins with Axel Ullrich's dedication to the concept that receptor tyrosine kinases must be the key to many human